Healthy adults who were not suffering from any diseases (excluding those under 18, pregnant women, and lactating women)
Conditions
Interventions
None listed
Sponsors
FUJIFILM Corporation
Yakujihou Marketing Jimusho Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: A systematic literature search is performed through scientific and clinical trial registries databases. The selection criteria are as follows. Participants (P): Healthy adults (excluding those under 18, pregnant women, and lactating women, who were not suffering from any diseases). Intervention (I): Intake of foods (tablets, capsules, granules, beverages, processed foods) containing Astaxanthin. Compositions that also contain ingredients other than Astaxanthin as test substances are excluded. Astaxanthin intake should be 0.4-30 mg/day. Comparison (C): The comparison group is set up as consuming a placebo food that does not contain Astaxanthin. Outcome (O): The primary outcomes are Skin moisture content as a measure of the ability to help protect skin moisture and Skin viscoelasticity as a measure of the ability to help protect skin elasticity. The secondary outcome is Transepidermal water loss as a measure of the ability to help protect skin moisture. Study design (S): Randomized, quasi-randomized, and non-randomized controlled trials (parallel group or crossover controlled trials) will be included.
Exclusion criteria
Exclusion criteria: Studies which do not meet the key inclusion criteria will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin moisture content, Skin viscoelasticity | — |
Secondary
| Measure | Time frame |
|---|---|
| Transepidermal water loss | — |
Countries
Japan
Contacts
Public ContactMami Sawada
FUJIFILM Corporation Consumer Healthcare Business Div.
Outcome results
None listed